CTI Life Sciences Fund makes venture capital investments in high-quality emerging life science companies at the pre-clinical and clinical development stages. Our main guiding principle is to catalyze, transform and invest in the future of life sciences across Canada, the U.S., and Europe. CTI Life Sciences Fund strategy revolves around the "Inception-2-Inflection" concept. We will invest from birthing new companies to more advanced-clinical-stage organizations. The Fund is driven by a complementary management team providing a deep scientific knowledge base, board management and governance experience, and business acumen. We seek highly differentiated and scalable ideas, that we will chaperone forward to growth.
